TY  - GEN
AU  - Jardim,Denis L Fontes
AU  - de Melo Gagliato,Debora
AU  - Falchook,Gerald S
AU  - Janku,Filip
AU  - Zinner,Ralph
AU  - Wheler,Jennifer J
AU  - Subbiah,Vivek
AU  - Piha-Paul,Sarina A
AU  - Fu,Siqing
AU  - Murphy,Mariela Blum
AU  - Ajani,Jaffer
AU  - Tang,Chad
AU  - Hess,Kenneth
AU  - Hamilton,Stanley R
AU  - Roy-Chowdhuri,Sinchita
AU  - Kurzrock,Razelle
AU  - Meric-Bernstam,Funda
AU  - Hong,David S
TI  - MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
SN  - 1949-2553
PY  - 2015///0127
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - DNA Mutational Analysis
KW  - DNA, Neoplasm
KW  - genetics
KW  - Disease-Free Survival
KW  - Esophageal Neoplasms
KW  - Esophagogastric Junction
KW  - Female
KW  - Gene Amplification
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Proto-Oncogene Proteins c-met
KW  - antagonists & inhibitors
KW  - Stomach Neoplasms
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.1828
ER  -